Search Results

US Hanford Submits Permit Modification Applications to Accelerate Tank Waste Cleanup via "Vitrification + Grouting"

The U.S. Department of Energy's Hanford Field Office recently submitted two permit modification applications to the Washington State Department of Ecology, planning to accelerate the cleanup of radioactive waste in tanks at the Hanford site through a dual-track treatment strategy of "vitrification + grouting." The DOE stated that this approach is expected to reduce risks from aging tanks and save taxpayers billions of dollars. The waste primarily targeted by these applications is low-activity liquid waste processed through the Tank-Side Cesium Removal system, which removes more than 99.9% of radioactive materials from the treated waste. The DOE stated that the proposed permit changes would integrate tank-side treatment, grout solidification, and out-of-state disposal into a standardized process to continue advancing the treatment and transfer of some waste beyond the capacity of the Waste Treatment and Immobilization Plant.

2026-08-11

OSI Systems Secures Approximately $11 Million Order to Supply Eagle M60 Mobile Cargo and Vehicle Inspection Systems

OSI Systems, Inc. announced on August 10 that its Security division has received an order worth approximately $11 million to supply Rapiscan® Eagle® M60 mobile cargo and vehicle inspection systems to an international customer, along with related operator training and maintenance training support. Ajay Mehra, President and CEO of OSI Systems, stated that the customer selected the Eagle M60 to enhance its cargo and vehicle inspection capabilities. The system offers advantages in mobile deployment and imaging performance, helping security and customs authorities conduct inspections at ports, border crossings, roadside checkpoints, and other scenarios while maintaining traffic flow efficiency. According to the company, the Rapiscan® Eagle®...

2026-08-11

Texas A&M University Leads Development of Novel Wound Treatment for New World Screwworm

On August 10, 2026, the Texas A&M Engineering Experiment Station is leading the development of fast-acting, low-residue wound treatments for livestock infected with New World screwworm. The project, funded at $1.86 million, is led by Dr. Mustafa E. S. Akbulut, Associate Professor in the Artie McFerrin Department of Chemical Engineering at Texas A&M University, with the goal of providing ranchers and veterinarians with immediately deployable field treatment tools after infection occurs in animals. New World screwworm is a parasite that feeds on living tissue. According to available data, the pest is currently spreading in Central America and Mexico, with over 150,000 animal infection cases reported. Recently, cases have also emerged in Texas and New Mexico. Federal models predict that a large-scale outbreak in Texas could result in livestock losses exceeding $1.8 billion. If left untreated, these pests can cause severe harm to livestock, companion animals, and wildlife.

2026-08-11

Morehead State University Receives $50,000 Grant to Support Nuclear Medicine Technology Bachelor's Program

Morehead State University in the United States recently received a $50,000 grant to strengthen its Bachelor of Science in Nuclear Medicine Technology program, supporting the university's efforts to train medical imaging professionals for Kentucky's healthcare system. The funding was provided by the Kentucky Board of Medical Imaging and Radiation Therapy and administered by the Kentucky Council on Postsecondary Education. The project funds were awarded through a competitive bidding process, with a focus on supporting nuclear medicine technology education programs in Kentucky, aiming to increase the number of qualified professionals entering the state's healthcare industry. The newly established nuclear medicine technology undergraduate program under Morehead State University's Department of Imaging Sciences will prepare students in the field of medical imaging...

2026-08-11

ITM Receives Complete Response Letter from FDA for ¹⁷⁷Lu-edotreotide New Drug Application

Radiopharmaceutical biotechnology company ITM Isotope Technologies Munich SE (ITM) announced on August 10 that it had received a Complete Response Letter (CRL) from the U.S. Food and Drug Administration (FDA) on August 7, 2026, regarding the New Drug Application (NDA) for its investigational drug ¹⁷⁷Lu-edotreotide (ITM-11). The drug is intended for the treatment of gastroenteropancreatic neuroendocrine tumors (GEP-NETs).

2026-08-11

Arab League Holds Second Technical Committee Meeting on Nuclear and Radiation Emergency Preparedness Roadmap, Focusing on Cross-Border Coordination and Alignment with IAEA Obligations

The General Secretariat of the League of Arab States held its second open-ended technical committee meeting at its headquarters from August 9 to 10, focusing on following up on the implementation of the Arab cooperation roadmap for nuclear and radiation emergency preparedness and response. The meeting was attended by representatives of Arab member states, the Arab Atomic Energy Agency (AAEA), and relevant Arab and international organizations, indicating that this issue has risen from mere technical cooperation to an important component of regional security governance. The core objective of the meeting is to enhance the coordination capacity and response capability of Arab countries in the face of nuclear accidents and radiological emergencies. As nuclear technology continues to expand in energy, medical, industrial, and scientific research applications, nuclear...

2026-08-10

Former U.S. President Biden's Prostate Cancer Progress: Has Received Radiation Therapy and Hormone Therapy

The health condition of former U.S. President Joe Biden has recently drawn renewed attention. In an interview video, his son Hunter Biden stated that after Biden was diagnosed with prostate cancer, the cancer cells had metastasized, spreading to the bones and other parts of the body, and described the process as extremely painful. According to relevant information, Biden, now 83 years old, disclosed in May 2025 that he had been diagnosed with an aggressive form of prostate cancer, with cancer cells confirmed to have spread to the bones at that time. In October, a Biden spokesperson announced that he was undergoing radiation therapy and hormone therapy. Radiation therapy is one of the common nuclear technology medical applications in tumor treatment, primarily using ionizing radiation on tumor tissue to...

2026-08-10

Grand Pharma's FAP-targeted diagnostic radiopharmaceutical GPN01530-2 receives FDA Fast Track designation

On August 9, 2026, Grand Pharmaceutical issued a voluntary announcement stating that its self-developed global innovative radionuclide drug conjugate GPN01530-2 has recently been granted Fast Track designation by the U.S. Food and Drug Administration (FDA) for the diagnosis of solid tumors. Previously, the product had already been approved by the FDA to conduct Phase I/II clinical studies for the diagnosis of solid tumors. GPN01530-2 is a small-molecule radionuclide drug conjugate (RDC) targeting fibroblast activation protein (FAP). Data shows that FAP is not expressed or is lowly expressed in normal tissues, but is highly expressed in tumor-associated fibroblasts within the tumor microenvironment of various cancers, and is considered a novel specific target in the field of tumor diagnosis and treatment...

2026-08-10

Hanford Site Completes Radioactive Waste Removal from 24th Underground Tank

The Hanford team under the U.S. Department of Energy Office of Environmental Management recently continued its tank cleanup mission, removing radioactive waste from the 24th underground single-shell tank. The cleanup targeted the A-106 single-shell tank. In less than seven months, Hanford Tank Waste Treatment and Storage Project workers transferred approximately 79,000 gallons of waste that had been stored for decades into a double-shell tank for continued safe storage. During operations, the contractor first used water to dissolve salt-based waste on the tank surfaces, then reused the transferred liquid waste to mobilize sludge. This method had last been used nearly a decade ago. The Hanford Site produced plutonium for U.S. nuclear weapons programs between 1944 and 1989...

2026-08-10

LLNL Research in the U.S. Reveals New Mechanisms of Laser Polarization Effects in NIF Inertial Confinement Fusion Experiments

Researchers at Lawrence Livermore National Laboratory (LLNL) have recently discovered in studies related to the National Ignition Facility (NIF) that the polarization state of lasers may influence the cross-beam energy transfer (CBET) process in inertial confinement fusion experiments and could help reduce backscatter and the risk of damage to optical components. The related paper, titled "Effects of Laser Polarization on Cross-Beam Energy Transfer in Inertial Confinement Fusion," was recently published as a featured article in the journal Physics of Plasmas. NIF experiments demand extremely high precision in laser control. The facility's 192 laser beams must be focused to a width of a few millimeters and enter the target area through holes approximately 3 millimeters in diameter located at the top or bottom of a gold hohlraum. The hohlraum is about 2 centimeters in diameter. After the lasers enter the plasma, different beams cross each other and undergo energy transfer, a process known as cross-beam energy transfer. When designing NIF inertial confinement fusion experiments, scientists carefully tune the laser wavelengths to use CBET to balance energy distribution and improve implosion symmetry.

2026-08-10

Microchip Launches Radiation-Tolerant Six-Output Programmable Clock Generator DSA504RT

Microchip Technology Inc. of the United States has launched the DSA504RT radiation-tolerant six-output programmable clock generator, targeting spacecraft and other aerospace and defense high-reliability electronic systems, designed to simplify timing architectures in complex systems. Spacecraft electronics typically require highly stable time references for missions such as navigation, communications, and scientific payloads, especially in environments where global navigation satellite system (GNSS) signals may be unavailable or subject to interference. Traditional solutions often rely on multiple oscillators, buffers, and timing devices to provide clock signals to different subsystems, resulting in increased component count, higher system mass, and greater circuit complexity...

2026-08-09

UAB startup LifeNuclear launches TheraGuide, a radiation safety guidance platform for radiopharmaceutical therapy

On August 7, LifeNuclear, a medical technology startup incubated by the University of Alabama at Birmingham (UAB), announced the launch of TheraGuide, a digital platform designed to help patients undergoing radiopharmaceutical cancer treatment understand and follow radiation safety guidance after discharge. Radiopharmaceutical therapy uses radioactive drugs to target cancer cells while minimizing damage to surrounding healthy tissue. As the therapy's applications expand, patients are typically required to read and follow complex written instructions after treatment, which can be difficult for some patients and caregivers to understand and execute. Dr. Remo George LifeNuclear was founded by UAB...

2026-08-08

DXA Screening Among U.S. Medicare Population Declines 35% Over Nearly Two Decades

A new study shows that between 2005 and 2023, the rate of dual-energy X-ray absorptiometry (DXA) examinations among U.S. Medicare beneficiaries declined significantly, by 35%. DXA is commonly used for bone density testing and osteoporosis-related screening, and the findings suggest that disparities in screening access across different populations are widening. Researchers analyzed claims data from more than 5 million Medicare beneficiaries. The results showed that DXA utilization fell from 7,255 exams per 100,000 beneficiaries in 2005 to 4,690 per 100,000 beneficiaries in 2023. The study was published in Osteoporosis International. The decline was not uniform across populations...

2026-08-08

DUNE Integrates Artificial Intelligence into Neutrino Experiment to Enhance Particle Detection and Data Processing Capabilities

The team at the U.S. Fermi National Accelerator Laboratory is advancing the Deep Underground Neutrino Experiment (DUNE) by integrating artificial intelligence and machine learning tools into experiment design, detector operations, and data analysis workflows, aiming to improve neutrino interaction identification, event classification, and detector management capabilities. Located at the Long-Baseline Neutrino Facility, DUNE has begun installing structural components for its large neutrino detector modules. The experiment consists of a near detector and a far detector: the near detector is situated at Fermilab, while the far detector is located approximately one mile underground at the Sanford Underground Research Facility in South Dakota. Both detectors will employ liquid argon time projection chamber technology to record neutrino...

2026-08-07

Oklo's Groves Isotope Test Reactor Achieves First Criticality

Oklo, a U.S. advanced nuclear technology company, announced on August 6 that its Groves Isotope Test Reactor has achieved a controlled self-sustaining nuclear chain reaction at low power, reaching first criticality. This milestone comes less than a year after the project broke ground. Groves Isotope Test Reactor facility (Image: Groves) The Groves low-power test reactor, located in Lockhart, Texas, is the first reactor to achieve criticality on private land under the U.S. Department of Energy's Reactor Pilot Program. According to Oklo, the facility was built from undeveloped land, completing civil excavation, engineering construction, component fabrication or procurement, fuel configuration, and...

2026-08-07